Categories: News

Increased Number of Shares and Votes in XVIVO Perfusion AB (publ)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

GOTHENBURG, SE / ACCESSWIRE / November 30, 2021 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)

As of today, 30 November 2021, the total number of shares and votes in XVIVO Perfusion AB (publ) is 29,498,666. The number of shares and votes has changed as a result of the directed new issue of 746,269 shares that the company announced on 28 October 2021.

November 30, 2021
XVIVO Perfusion AB (publ)

For further information, please contact:

Dag Andersson, CEO, +46 76 643 30 31, e-mail: dag.andersson@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com

About Us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs – so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.

This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2021-11-30 08:00 CET.

Attachments

Increased number of shares and votes in XVIVO Perfusion AB (publ)

SOURCE: XVIVO Perfusion AB

View source version on accesswire.com:
https://www.accesswire.com/675218/Increased-Number-of-Shares-and-Votes-in-XVIVO-Perfusion-AB-publ

Staff

Recent Posts

NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING

HOUSTON, June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:…

4 hours ago

Sony, SCREEN, and VitroVo to Start Trial Offer of MEA System Capable of Simultaneous Measuring and Recording Data from Approximately 237,000 Electrodes

Contributing to high-definition visualization of cellular activity and supporting research into neuronal and cardiac diseases…

4 hours ago

PAIG AI Rebrands as Trust3 AI to Lead the Way in Trusted AI Adoption

SAN FRANCISCO, June 2, 2025 /PRNewswire/ -- PAIG AI, a leading provider of AI governance…

4 hours ago

Delivra Health Brands, and Its Dream Water(R) Brand, Partners with QVC to Bring Dream Water to Online Shoppers Across the US

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB:…

11 hours ago

Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company")…

14 hours ago

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical…

16 hours ago